TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014. The award honors an individual or a company with a new disruptive technology platform that has increased the efficiency and quality of clinical trials. TrialNetworks technology is used by companies including Merck, Biogen Idec, Ariad Pharmaceuticals and Infinity Pharmaceuticals to optimize clinical operations from startup through closeout.

Megan Knapp, managing director of the Pharmaceutical and Healthcare Division at conference organizer IIR U.S., said, “Our expert Partnerships Advisory Board comprised of more than 30 expert clinical research leaders chose the TrialNetworks Clinical Trial Optimization System as the 2014 winner from a field of strong finalists. According to customers and users experienced with the platform, TrialNetworks is breaking significant new ground in enabling sponsors, CROs and sites to make meaningful improvements in clinical operations through efficient collaboration and process improvement.”